Clinical Chemistry AACC Online Job Center
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 52: 1435-1436, 2006; 10.1373/clinchem.2006.066753
This Article
Right arrow Extract Freely available
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via ISI Web of Science (1)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jaleel, A.
Right arrow Articles by Abraham, R. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jaleel, A.
Right arrow Articles by Abraham, R. S.
Related Collections
Right arrow Proteomics and Protein Markers
Right arrow Hematology
(Clinical Chemistry. 2006;52:1435-1436.)
© 2006 American Association for Clinical Chemistry, Inc.


Letters to the Editor

Bence Jones Cryoglobulinuria: Characterization of a Urinary {kappa} Light Chain Cryoglobulin

Abdul Jaleel1,1, Barbara A.L. Owen2,1, Michelle K. Manske3, Jerry A. Katzmann4, Robert A. Kyle3 and Roshini S. Abraham4,a

1 Endocrine Research Unit, Department of Medicine,2 Biochemistry and, Molecular Biology and, Molecular Pharmacology and, Experimental Therapeutics,3 Division of Hematology and,4 Division of Clinical, Biochemistry and Immunology, Department of Laboratory, Medicine and Pathology, Mayo Clinic College of Medicine, Rochester, MN

aAddress correspondence to this author at: Division of Clinical Biochemistry and Immunology, Department of Laboratory Medicine and Pathology, Hilton 210e, Mayo Clinic, Rochester, MN 55905. Fax 507-266-4088; e-mail abraham.roshini{at}mayo.edu.


To the Editor:

Bence Jones protein with cryoglobulin properties is rare. One of the earliest reports of Bence Jones cryoglobulinuria was made by Alper in 1966 (1) on a patient with multiple myeloma who had a {lambda} Bence Jones cryoglobulin (cryo) in the urine. In this letter, we report a patient with {kappa} Bence Jones cryoglobulinuria. We performed physicochemical analysis of the cryo protein and compared it with a noncryo monoclonal urinary {kappa} light chain to improve our understanding of the molecular basis of urine cryoglobulin formation.

The patient was a 73-year-old male who had clinical and laboratory findings consistent with multiple myeloma. Serum immunofixation revealed a monoclonal {kappa} light chain. Urine protein electrophoresis and immunofixation of a randomly collected urine sample revealed the presence of a monoclonal {kappa} Bence Jones protein. This urine sample formed a gel at 4 °C, which disappeared when the sample was warmed to 37 °C. As a control, we used the urine from a myeloma patient with {kappa} Bence Jones protein without cryo formation.

We performed single-dimension sodium dodecyl sulfate–polyacrylamide gel electrophoresis (SDS-PAGE) on the control and cryo urine samples, which revealed a single band at a relative molecular mass (Mr) of 25 000, consistent with monoclonal {kappa} light chain (Fig. 1 ). We then performed gel-filtration chromatography at 4 °C in either "no salt" or "plus NaCl" buffer. Gel-filtration chromatography of the cryo light chain protein in the presence of 100 mmol/L NaCl showed 2 peaks with apparent Mr of 24 000 (29%) and 48 000 (71%). These data indicate that there was a similar distribution of monomeric and dimeric protein species compared with the control light chain; however, the cryo protein was much more compact (spherical) than the control protein in moderate salt solution. In the absence of salt, the cryo protein had an Mr of 68 000, or an apparent mass 2.8-fold larger than that observed in the presence of 100 mmol/L salt. The change in the dimeric form is more dramatic, with an Mr of 280 000, a 5.8-fold increase in apparent mass (Fig. 1 ). Because gel-filtration measurements reflect both the mass and shape of the protein, this technique is insufficient of itself to determine whether the cryo light chain has undergone additional polymerization, a large change in conformation, or a combination of both (2)(3). The control Bence Jones protein had 2 molecular species that were consistent with monomer and dimer in the presence or absence of physiologic concentrations of salt.


Figure 1
View larger version (32K):
[in this window]
[in a new window]
 
Figure 1. Single-dimension SDS-PAGE (top) and gel-filtration analysis (bottom) of the urine cryo sample.

Run under reducing conditions, SDS-PAGE revealed a single dominant band at Mr 25 000 for both the cryo and the control {kappa} light chain proteins. The cryo urine sample was equilibrated, desalted, and run on a gel-filtration column at 4 °C to analyze the various molecular species in the presence (black line) or absence (gray line) of 100 mmol/L NaCl. The cryo protein has 2 molecular species, corresponding to monomer (24 000) and dimer (48 000), present in similar proportions of ~70% and ~30%, respectively, in the presence of 100 mmol/L NaCl. In the absence of salt, the apparent Mr is substantially increased, with the 24 000 species now having an Mr of 68 000 and the dimeric form of the protein also increasing in Mr to 280 000, with a distribution of 76% and 24%, respectively.

Sedimentation equilibrium experiments were performed on the cryo {kappa}-light chain protein that had been preequilibrated in the no-salt buffer and run at 6000 and 12 000 rpm at 20 °C (analysis could not be performed at 4 °C because of protein precipitation at higher concentrations). Sedimentation equilibrium centrifugation analysis with a self-association model revealed that the mean molecular mass of the cryo protein in the absence of salt at 20 °C was Mr 60 000. The sedimentation data were consistent with a mixture of 70% dimers and 30% tetramers.

Early studies investigating the mechanisms of temperature- and concentration-dependent cryoprecipitation have shown that low temperatures change the intramolecular environment of the protein, particularly with certain aromatic residues (4). It is possible that there are both salt- and temperature-dependent changes at 20 °C and that only the salt-dependent changes in polymerization are detected by either sedimentation equilibrium or by the apparent Mr measured by gel filtration at 4 °C. Low salt accurately reflects the presence of trimers and hexamers that would form a cryoprecipitate at the higher concentration of light chain protein found in undiluted urine stored at 4 °C. The sodium concentration in urine can vary considerably, and we did not ascertain the sodium in the urine of the cryo patient. It is noteworthy, however, that the control {kappa} light chain did not show any salt-dependent changes in relative molecular mass, unlike the cryo protein.

It is likely that several physicochemical factors contributed to urine cryoglobulin formation in this patient, including the immunoglobulin light chain protein sequence, resulting from the inherent diversity in the variable regions of immunoglobulins, and the concentration, because the protein had to be diluted substantially to prevent precipitation on the gel-filtration column at 4 °C. In addition, there was no evidence of clinical symptoms related to the urine cryo at physiologic temperature. The urine remained a clear liquid at room temperature and 37 °C and showed complete gel formation only at 4 °C. However, because we do not have data to confirm the role of these various factors, the extent to which these may have contributed to cryo formation in this patient remains speculative.


Footnotes

1 These authors contributed equally to this work.


References

  1. Alper CA. Cryoglobulinuria: studies of a cryo-Bence Jones protein. Acta Med Scand Suppl 1966;445:200-205.[Medline] [Order article via Infotrieve]
  2. Richter W. Determining the subunit structure of phosphodiesterases using gel filtration and sucrose density gradient centrifugation. Methods Mol Biol 2005;307:167-180.[Medline] [Order article via Infotrieve]
  3. Narayanan S, Reif B. Characterization of chemical exchange between soluble and aggregated states of ß-amyloid by solution-state NMR upon variation of salt conditions. Biochemistry (Mosc) 2005;44:1444-1452.
  4. Middaugh CR, Thomas GJ, Jr, Prescott B, Aberlin ME, Litman GW. Investigations of the molecular basis for the temperature-dependent insolubility of cryoglobulins: II. spectroscopic studies of the IgM monoclonal cryoglobulin McE. Biochemistry (Mosc) 1977;16:2986-2994.[CrossRef][Medline] [Order article via Infotrieve]




This Article
Right arrow Extract Freely available
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via ISI Web of Science (1)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jaleel, A.
Right arrow Articles by Abraham, R. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jaleel, A.
Right arrow Articles by Abraham, R. S.
Related Collections
Right arrow Proteomics and Protein Markers
Right arrow Hematology


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS